Correlation Between Viridian Therapeutics and Kalvista Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viridian Therapeutics and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Viridian Therapeutics and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Kalvista Pharmaceuticals.

Diversification Opportunities for Viridian Therapeutics and Kalvista Pharmaceuticals

-0.79

Correlation Coefficient

Viridian Therapeutics  Kalvista Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Viridian and Kalvista is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Kalvista Pharmaceuticals go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Kalvista Pharmaceuticals

Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Kalvista Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Viridian Therapeutics is 1.0 times less risky than Kalvista Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Kalvista Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  839.00  in Kalvista Pharmaceuticals on December 30, 2024 and sell it today you would earn a total of  354.00  from holding Kalvista Pharmaceuticals or generate 42.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Viridian Therapeutics  vs.  Kalvista Pharmaceuticals

Viridian Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Viridian Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Kalvista Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Kalvista Pharmaceuticals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Kalvista Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Viridian Therapeutics and Kalvista Pharmaceuticals

The main advantage of trading using opposite Viridian Therapeutics and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.

The idea behind Viridian Therapeutics and Kalvista Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.